Join Our Movement to Restore Your Right to Pain Relief! #EndPainPatientAbuse
Pain Warriors Unite - (202) 792-5600
U.S. CONGRESS WILL BE ON BREAK
FOR THE MONTH OF AUGUST.
The upcoming August recess is a great opportunity for you to set up a private meeting with your members of Congress or to attend any local Events (Town Hall Meetings, Meet & Greets, Campaign Events, etc.) to address our cause.
CLICK HERE TO LOCATE YOUR STATE & FEDERAL REPRESENTATIVES
You can find upcoming events in your State HERE: https://indivisible.org/events
Please let us know if you need assistance setting up a meeting or if you'd like a packet of materials to bring along.
Instructions , Tips, and Links to locate & Contact Your State and Federal Representatives & Regulatory Agencies
Please use our handy Legislative Outreach Kit & ask for assistance if necessary. The only way to change the current pathway which has created a hostile regulatory environment is to GET INVOLVED IN THE LEGISLATIVE PROCESS ASAP
RE: Overview of Pain Management Task Force Meeting & Recommendations
View Task Force's Final Report HERE
The purpose of this final meeting was for the Task Force members to disseminate and discuss the final report in full detail. They debated and deliberated to carefully refine the language and terminology to avoid future misinterpretation or misapplication. They reviewed the consensus of thousands of comments submitted by the public during the previous public comment
What can YOU do to help?
If you need help, please let us know & we'll be happy to provide the information you'll need!
It's best to call their local offices directly and request to schedule a meeting or telephone conference with their health care staffer,
CLICK BELOW TO LOCATE & CONTACT YOUR STATE AND FEDERAL REPRESENTATIVES DURING BUSINESS HOURS!
April 26th report by Shepard Smith about the harms to chronic pain patients as a result of the overarching CDC Guidelines.
Link to Video: https://youtu.be/2Jg0ZV9ftFE
Fox News' Greg Gutfeld has been reporting about our plight for several months. Watch the most recent segment about the CDC Clarification featured on "The Five"
Watch segment here:
** URGENT BULLETIN ** Please SHARE with all State& Federal Representatives and Regulatory Agencies in charge of regulating Controlled Substances/Opioid prescribing.
Re: CDC Guideline Clarification Letter & FDA Advisory Notice pertaining to Opioid Prescribing
Below is a letter from the CDC clarifying the 2016 Opioid Prescribing Guideline and an Advisory Notice issued by the FDA regarding abrupt opioid tapering.
The Guideline is not intended to deny any patients who suffer with chronic pain from receiving opioid therapy as an option for pain management. Rather, the Guideline is intended to ensure that clinicians and patients consider all safe and effective treatment options for patients.
Clinical decision-making should be based on the relationship between the clinician and patient, with an understanding of the patient’s clinical situation, functioning, and life context, as well as a careful consideration of the benefits and risk of all treatment options, including opioid therapy.
CDC encourages physicians to continue to use their clinical judgment and base treatment on what they know about their patients, includes the use of opioids if determined to be the best course of treatment. Providers should communicate frequently with their patients to discuss both the benefits and risks of opioid therapy and revisit treatment plans for pain regularly to achieve the most positive outcomes for patients.
Reports of "serious harm" in patients dependent on opioid painkillerswho suddenly stop taking the medication, or rapidly decrease the dose, have prompted a drug safety communication issued today by the US Food and Drug Administration (FDA).
The U.S. Department of Health and Human Services Office for Civil Rights has released new guidance explaining when HIPAA permits health care providers and other covered entities to share a patient’s health information with loved ones and others involved in a patient’s care in these situations.
The guidance explains:
**URGENT PRESS RELEASE** 2nd LETTER FROM CDC RESPONDING TO THE HP3 LETTER RELEASED TODAY!
FOR IMMEDIATE RELEASE APRIL 10, 2019
TWO FEDERAL AGENCIES SPEAK AGAINST MANDATED OR PRECIPITOUS OPIOID REDUCTIONS IN CHRONIC PAIN PATIENTS
On April 10, the Director for the Centers for Disease Control and Prevention, Dr. Robert Redfield, wrote to Health Professionals for Patients in Pain (HP3) to state that the CDC’s 2016 Guideline offered no support for mandatory opioid dose reductions in patients with long-term pain. Coming on the heels of an April 9 warning from the United States Food and Drug Administration of “serious harm” to patients after rapid dose reduction or discontinuation, the Director’s letter flags the need for a recalibration of care decisions imposed by a wide range of private and governmental agencies that have invoked the CDC to justify coverage restrictions, quality metrics, legal threats and other actions to force dose reductions on nonconsenting patients.
Please CLICK BELOW to read Press Release & Access the CDC Director's Letter responding to the HP3 Letter
The National Association of Attorneys General (NAAG) has sent a letter to the U.S. Department of Health and Human Services (HHS) sharing concerns about the Pain Management Best Practices Inter-Agency Task Force Draft Report (Draft Report). The letter was addressed to Dr. Vanila Singh, chief medical officer for the Office of the Assistant Secretary for Health.
As it stands, the Draft Report deviates from guidelines published by the Centers for Disease Control and Prevention (CDC), which are aimed at decreasing the risk of opioid misuse. The report suggests providers can rely solely on their judgement instead of consulting evidence-based recommendations. By doing so, it weakens recommendations for opioid prescription duration and dosage.
“As attorneys general, we have witnessed the devastating effect of unfettered opioid manufacturing, distribution and prescribing on our public health, social services and criminal justice systems. The well-established risks associated with higher doses of opioids, prescriptions of longer duration, and concurrent prescriptions of opioids and benzodiazepines demand continued constraints.”
Read the NAAG letter signed by 39 state and territory attorneys general.
If your State Attorney General signed this damning letter to the Pain Management Task Force, please call or email him/her to share your disdain & disappointment. Also, request To schedule a meeting.
Find your Attorney General HERE
Click button to read the letter to the Task Force in its entirety.
Please get involved NOW by completing the latest Calls to Action and Team Tasks.
Our collective efforts are making a HUGE difference no matter how big or small.
We need YOU to take the time to do whatever you can to be victorious in this fight for our LIVES.
CLICK BELOW TO COMPLETE THE LATEST TEAM TASKS.
Sign up to Stay up to Date on the Latest News, Alerts, Deadlines, Calls to Action & Events Happening in the Pain Community.